Fig. 3.
Disease-free survival (a, c) and overall survival (b, d) rates between patients with stage II (a, b) and I (c, d) HR(−)/HER2(−) tumors and those with stage III (a, b) and II (c, d) HR(+)/HER2(−) tumors using the anatomic staging system
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.